Gene: B3GALT9
Official Full Name: beta-1,3-galactosyltransferase 9provided by HGNC
Gene Summary: Predicted to enable glycosyltransferase activity. Predicted to be involved in protein O-linked glycosylation. Predicted to be located in Golgi apparatus and membrane. Predicted to be active in Golgi membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19505 | B3GALT9 Knockout cell line (HeLa) | Human | B3GALT9 | 1:3~1:6 | Negative | Online Inquiry |
KO19506 | B3GALT9 Knockout cell line (HCT 116) | Human | B3GALT9 | 1:2~1:4 | Negative | Online Inquiry |
KO19507 | B3GALT9 Knockout cell line (HEK293) | Human | B3GALT9 | 1:3~1:6 | Negative | Online Inquiry |
KO19508 | B3GALT9 Knockout cell line (A549) | Human | B3GALT9 | 1:3~1:4 | Negative | Online Inquiry |
B3GALT9 Gene Knockout Cell Lines represent a significant advancement in cellular biology, specifically designed to investigate the function of the B3GALT9 gene, which plays a critical role in glycan biosynthesis and cellular signaling pathways. These cell lines are engineered to lack functional B3GALT9, thereby providing researchers with a powerful tool for examining the gene’s contribution to various biological processes, including cell adhesion, growth, and immune response modulation.
The mechanism underpinning these knockout cell lines involves targeted gene disruption through CRISPR-Cas9 technology, allowing for precise editing of the genomic sequence. This targeted approach not only confirms the absence of the B3GALT9 gene but also enables downstream analyses of cellular behavior, interactions, and metabolic pathways specifically influenced by this gene. Consequently, these cell lines serve as a valuable model for studying disease mechanisms, particularly those related to glycosylation disorders and cancer metastasis.
In research and clinical contexts, B3GALT9 Gene Knockout Cell Lines are invaluable for elucidating the impacts of glycan structures on various biological functions and their implications in disease. They provide a distinct advantage in studies exploring novel therapeutic targets, enhancing the understanding of cell biology, and facilitating drug discovery efforts by allowing for the screening of compounds that may interact with abnormal cellular signaling.
What sets these knockout cell lines apart from alternative models is their specificity and the thorough validation process, ensuring that researchers obtain reliable data that reflects genuine biological responses. Additionally, the cell lines offer consistent performance, scalability for high-throughput applications, and a user-friendly framework for experimentation.
For researchers and clinicians aiming to deepen their understanding of cellular mechanisms associated with the B3GALT9 gene, these knockout cell lines present unmatched versatility and reliability. Leveraging our company's extensive experience and commitment to quality in biological products, we provide exceptional resources that empower innovations in research and therapeutic applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.